Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer

Oncogene volume 25, pages 4998–5010 (2006)Cite this article

Abstract

Mammary tumor cells are required to degrade the surrounding matrix and disseminate in order to metastasize, and both of these processes are controlled by a tumor cell-signaling network that remains poorly defined. MEKK1 is a MAPKKK that regulates both the extracellular signal regulated kinase (ERK1/2) and the c-Jun amino terminal kinase (JNK) signaling pathways. MEKK1 signaling regulates migration through control of cell adhesion and is required for inducible expression of urokinase-type plasminogen activator (uPA). MEKK1-deficient mice with mammary gland-targeted expression of the polyoma middle T antigen (PyMT) transgene develop primary mammary tumors at a rate and frequency similar to wild-type littermates, indicating that MEKK1 deficiency does not affect PyMT-mediated transformation. However, MEKK1−/− mice display significantly delayed tumor cell dissemination and lung metastasis. Delayed MEKK1-dependent tumor dissemination is associated with markedly reduced tumor uPA expression, gelatinase activity, and prolonged tumor basement membrane integrity. siRNA-mediated MEKK1 knockdown inhibits uPA activity, cell migration and invasion in MDA-MB-231 human breast cancer cells. Thus MEKK1 controls tumor progression by regulating both the migration and proteolysis aspects of tumor cell invasiveness. To our knowledge, this is the first example of a MAPKKK that regulates metastasis through control of tumor invasiveness.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Ahmed F, Wyckoff J, Lin EY, Wang W, Wang Y, Hennighausen L et al. (2002). Cancer Res 62: 7166–7169.

  • Almholt K, Lund LR, Rygaard J, Nielsen BS, Dano K, Romer J et al. (2005). Int J Cancer 113: 525–532.

  • Andreasen PA, Kjoller L, Christensen L, Duffy MJ . (1997). Int J Cancer 72: 1–22.

  • Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G et al. (2000). Clin Exp Metastasis 18: 171–178.

  • Bianco Jr FJ, Gervasi DC, Tiguert R, Grignon DJ, Pontes JE, Crissman JD et al. (1998). Clin Cancer Res 4: 3011–3016.

  • Bogenrieder T, Herlyn M . (2003). Oncogene 22: 6524–6536.

  • Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB et al. (1987). Proc Natl Acad Sci USA 84: 5763–5767.

  • Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF et al. (1998). Oncogene 16: 3097–3104.

  • Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). Oncogene 19: 968–988.

  • Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA . (1996). Int J Cancer 66: 441–452.

  • Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D, Verde P . (1999). Mol Cell Biol 19: 6240–6252.

  • Cuevas BD, Abell AN, Witowsky JA, Yujiri T, Johnson NL, Kesavan K et al. (2003). Embo J 22: 3346–3355.

  • Cuevas BD, Uhlik MT, Garrington TP, Johnson GL . (2005). Oncogene 24: 801–809.

  • Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T et al. (1993). Cancer Res 53: 5365–5369.

  • D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B et al. (1997). Gene 201: 179–187.

  • Duffy MJ . (2004). Ann Clin Biochem 41: 370–377.

  • Duffy MJ, Duggan C . (2004). Clin Biochem 37: 541–548.

  • Egeblad M, Werb Z . (2002). Nat Rev Cancer 2: 161–174.

  • el Yazidi I, Boilly-Marer Y . (1995). Anticancer Res 15: 783–790.

  • Fanger GR, Johnson NL, Johnson GL . (1997). Embo J 16: 4961–4972.

  • Fidler IJ . (1991). Acta Oncol 30: 668–675.

  • Fincham VJ, James M, Frame MC, Winder SJ . (2000). Embo J 19: 2911–2923.

  • Frederiks WM, Mook OR . (2004). J Histochem Cytochem 52: 711–722.

  • Fuchs SY, Dolan L, Davis RJ, Ronai Z . (1996). Oncogene 13: 1531–1535.

  • Glading A, Chang P, Lauffenburger DA, Wells A . (2000). J Biol Chem 275: 2390–2398.

  • Guy CT, Cardiff RD, Muller WJ . (1992). Mol Cell Biol 12: 954–961.

  • Hamasaki T, Hattori T, Kimura G, Nakazawa N . (1998). Urol Res 26: 371–376.

  • Huang C, Jacobson K, Schaller MD . (2004). J Cell Sci 117: 4619–4628.

  • Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K . (2003). Nature 424: 219–223.

  • Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S . (1998). Cancer Res 58: 1048–1051.

  • Karin M, Liu Z, Zandi E . (1997). Curr Opin Cell Biol 9: 240–246.

  • Lapidus RG, Nass SJ, Davidson NE . (1998). J Mammary Gland Biol Neoplasia 3: 85–94.

  • Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D . (1998). Arterioscler Thromb Vasc Biol 18: 1035–1045.

  • Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ et al. (2003). Am J Pathol 163: 2113–2126.

  • Nielsen BS, Sehested M, Timshel S, Pyke C, Dano K . (1996). Lab Invest 74: 168–177.

  • Nielsen BS, Sehested M, Duun S, Rank F, Timshel S, Rygaard J et al. (2001). Lab Invest 81: 1485–1501.

  • Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot A, van Tienoven DT et al. (2004). Cancer 101: 486–494.

  • Meijer-van Gelder ME, Look MP, Peters HA, Schmitt M, Brunner N, Harbeck N et al. (2004). Cancer Res 64: 4563–4568.

  • Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC et al. (2004). Proc Natl Acad Sci USA 101: 1892–1897.

  • Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Sturzebecher A, Schuster O et al. (2004). J Biol Chem 279: 33613–33622.

  • Sidenius N, Blasi F . (2003). Cancer Metastasis Rev 22: 205–222.

  • Sieuwerts AM, Klijn JG, Henzen-Logmans SC, Foekens JA . (1999). Breast Cancer Res Treat 55: 9–20.

  • Stamenkovic I . (2000). Semin Cancer Biol 10: 415–433.

  • Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T . (2004). Gynecol Oncol 94: 725–734.

  • Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT et al. (2004). Nat Cell Biol 6: 154–161.

  • Westermarck J, Kahari VM . (1999). Faseb J 13: 781–792.

  • Witowsky J, Abell A, Johnson NL, Johnson GL, Cuevas BD . (2003). J Biol Chem 278: 5941–5946.

  • Yujiri T, Sather S, Fanger GR, Johnson GL . (1998). Science 282: 1911–1914.

  • Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E et al. (2000). Proc Natl Acad Sci USA 97: 7272–7277.

Download references

Acknowledgements

We thank Noah Sciaky for his assistance with confocal microscopy. This work was supported by National Institutes of Health grants GM30324 and DK37871.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    B D Cuevas, A M Winter-Vann, N L Johnson & G L Johnson

Authors
  1. B D Cuevas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A M Winter-Vann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N L Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G L Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to B D Cuevas or G L Johnson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuevas, B., Winter-Vann, A., Johnson, N. et al. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer. Oncogene 25, 4998–5010 (2006). https://doi.org/10.1038/sj.onc.1209507

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209507

Keywords

This article is cited by

Search

Advanced search

Quick links